We are live on
!
Find out more
SR
Syntax Research Portfolio holdings
AUM
$157M
1-Year Est. Return
16.51%
This Fund
S&P 500
This Quarter
Est. Return
+7.32%
1 Year Est. Return
+16.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$141M
AUM Growth
-$4.04M
(-2.8%)
Cap. Flow
-$11.9M
Cap. Flow
% of AUM
-8.48%
Top 10 Holdings %
Top 10 Hldgs %
46.39%
Holding
182
New
7
Increased
31
Reduced
30
Closed
12
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
+$2.35M |
| 2 |
Zoetis
ZTS
|
+$2.21M |
| 3 |
Willis Towers Watson
WTW
|
+$2.17M |
| 4 |
Palo Alto Networks
PANW
|
+$2.16M |
| 5 |
Accenture
ACN
|
+$2.03M |
Top Sells
| 1 |
Nutrien
NTR
|
+$3.4M |
| 2 |
American Tower
AMT
|
+$3.32M |
| 3 |
Newmont
NEM
|
+$3.21M |
| 4 |
Americold
COLD
|
+$2.6M |
| 5 |
Merck
MRK
|
+$2.39M |
Sector Composition
| 1 | Technology | 19.94% |
| 2 | Healthcare | 5.03% |
| 3 | Industrials | 4.92% |
| 4 | Financials | 4.5% |
| 5 | Materials | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
iShares Core S&P 500 ETF
IVV
$881B
| $15M | 10.67% |
24,188
+1,052
| +5% | +$604K |
|
2
iShares MSCI USA Value Factor ETF
VLUE
$9.6B
| $7.88M | 5.6% |
69,620
+9,328
| +15% | +$984K |
|
3
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $7.15M | 5.08% |
74,674
+12,099
| +19% | +$1.14M |
|
4
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
| $6.84M | 4.86% |
82,516
-6,822
| -8% | -$563K |
|
5
Apple
AAPL
$4.89T
| $5.91M | 4.2% |
28,808
-83
| -0.3% | -$16.8K |
|
6
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.7B
| $5.52M | 3.92% |
109,618
+9,454
| +9% | +$467K |
|
7
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $5.02M | 3.56% |
8,122
+54
| +0.7% | +$30.9K |
|
8
Broadcom
AVGO
$1.78T
| $4.22M | 3% |
15,327
-2,025
| -12% | -$440K |
|
9
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $3.97M | 2.82% |
64,058
-561
| -0.9% | -$32.9K |
|
10
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$35.2B
| $3.78M | 2.68% |
34,468
+4,208
| +14% | +$452K |
|
11
iShares Core S&P Small-Cap ETF
IJR
$110B
| $3.55M | 2.52% |
32,460
-395
| -1% | -$40.8K |
|
12
Alphabet (Google) Class C
GOOG
$4.32T
| $3.51M | 2.5% |
19,815
-990
| -5% | -$164K |
|
13
Microsoft
MSFT
$2.98T
| $3.41M | 2.42% |
6,852
+2
| +0% | +$869 |
|
14
Arista Networks
ANET
$212B
| $3.17M | 2.25% |
30,977
+8,977
| +41% | +$777K |
|
15
Prologis
PLD
$140B
| $2.98M | 2.12% |
28,352
-3,716
| -12% | -$390K |
|
16
Qualcomm
QCOM
$180B
| $2.9M | 2.06% |
18,240
+3,397
| +23% | +$500K |
|
17
Freeport-McMoran
FCX
$84.2B
| $2.74M | 1.95% |
63,246
-20,392
| -24% | -$774K |
|
18
Oracle
ORCL
$358B
| $2.73M | 1.94% |
12,501
+1,501
| +14% | +$242K |
|
19
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
| $2.67M | 1.9% |
43,856
-25,632
| -37% | -$1.48M |
|
|
20
Palo Alto Networks
PANW
$289B
| $2.38M | 1.69% |
+11,646
| New | +$2.16M |
|
|
21
Thermo Fisher Scientific
TMO
$202B
| $2.32M | 1.64% |
5,711
+5,623
| +6,390% | +$2.35M |
|
22
FedEx
FDX
$75.9B
| $2.26M | 1.61% |
9,945
+5
| +0.1% | +$1.09K |
|
23
JPMorgan Chase
JPM
$912B
| $2.24M | 1.59% |
7,717
+109
| +1% | +$27.8K |
|
24
iShares Core MSCI Europe ETF
IEUR
$8.69B
| $2.2M | 1.57% |
33,291
-23,563
| -41% | -$1.49M |
|
|
25
Zoetis
ZTS
$32.2B
| $2.17M | 1.54% |
+13,918
| New | +$2.21M |
|
Similar funds
BRWM
SF
AC
HEM
EP
CF
TPBG
CFG
Syntax Research's Q2 2025 Portfolio in Review
As of Q2 2025, Syntax Research held 182 positions worth $141M, down 2.8% from $145M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Syntax Research withdrew a net $11.9M in Q2 2025, closing 12 positions and reducing 30 holdings. Its most notable exit was Americold, an estimated $2.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Syntax Research opened a new position in Zoetis worth $2.17M.
- Syntax Research's largest Q2 2025 buy was Zoetis: 13,918 shares worth $2.17M.
- Syntax Research added most to Thermo Fisher Scientific in Q2 2025, an estimated $2.35M increase.
- Syntax Research's biggest Q2 2025 reduction was Nutrien, cutting an estimated $3.4M.
- Syntax Research fully exited Americold in Q2 2025, selling an estimated $2.6M.
- Syntax Research's ten largest holdings make up 46% of its $141M portfolio in Q2 2025.
- Syntax Research opened 7 new positions and closed 12 in Q2 2025.
- Syntax Research's portfolio value fell 2.8% quarter-over-quarter to $141M.
Based on Syntax Research's 13F filing for Q2 2025, filed 21 Jul 2025.